Kangmei Pharmaceutical Co., Ltd. (600518) - Pharmaceuticals & Healthcare - Deals and Alliances Profile by GlobalData

VIEWS: 1 PAGES: 21

Kangmei Pharmaceutical Co., Ltd. (Kangmei) is a pharmaceutical company, based in China. The company manufactures and sells herbal raw materials and preparations. Its products include notoginseng powder, salvia powder, radix codonopsis pilosulae, maltiflower knotweed, angelica and lonicera flower. Kangmei also provides chemical drugs such as, clarithromycin dispersible tablets, doxazosin mesylate tablets, propiverine hydrochloride tablets and paracetamol and pseudoephedrine hydrochloride tablets. The company is affiliated with Hong Mei Shanghai Branch, Hong Mei Bozhou century Sinopharm, Kangmei Jian Kang Products Division and Combibloc Xinkaihe Pharmaceutical among others. It has its presence in Beijing, Shanghai and Hong Kong. Kangmei is headquartered in Puning, China.

More Info
									        Kangmei Pharmaceutical Co., Ltd. (600518) - Pharmaceuticals & Healthcare -
                             Deals and Alliances Profile
       Reference Code: GDPH197245D                                                                                                              Publication Date: MAR 2013

      Company Overview                                                                                        Key Facts
      Kangmei Pharmaceutical Co., Ltd. (Kangmei) is a pharmaceutical company, based
                                                                                                              Kangmei Pharmaceutical Co., Ltd., Pharmaceuticals
      in China. The company manufactures and sells herbal raw materials and
                                                                                                              & Healthcare, Key Facts, 2011
      preparations. Its products include notoginseng powder, salvia powder, radix
      codonopsis pilosulae, maltiflower knotweed, angelica and lonicera flower. Kangmei                        Web Address                           www.kangmei.com.cn
      also provides chemical drugs such as, clarithromycin dispersible tablets, doxazosin
                                                                                                               Revenue (US$ million)                                      939.80
      mesylate tablets, propiverine hydrochloride tablets and paracetamol and
      pseudoephedrine hydrochloride tablets. The company is affiliated with Hong Mei                           Number of Employees                                         4,110
      Shanghai Branch, Hong Mei Bozhou century Sinopharm, Kangmei Jian Kang                                    GlobalData
      Products Division and Combibloc Xinkaihe Pharmaceutical among others.

      Financial Deals Landscape
        Kangmei Pharmaceutical Co., Ltd., Pharmaceuticals &                               Kangmei Pharmaceutical Co., Ltd., Pharmaceuticals &
        Healthcare, Deals by Type, 2007 to YTD 2013                                       Healthcare, Deals By Year, 2007 to YTD 2013


                                                                                                                                   3
                                                                                                          3


                                                                                           No. of Deals
                                                                                                                                            2
                                                                                                          2

                                                                                                                 1        1                          1
                                                                                                          1

                                                                                                                                                           0        0
                                                                                                          0
                                                                                                               2007     2008   2009       2010    2011    2012     YTD
                                                                                                                                                                   2013


                                                                                          Note: Deals include all announced pharmaceuticals & healthcare deals
         Note: Deals include all announced pharmaceuticals & healthcare deals from
                                                                                          from 2006 onwards, GlobalData
         2006 onwards, GlobalData


         Kangmei Pharmaceutical Co., Ltd., Pharmaceuticals &                              Kangmei Pharmaceutical Co., Ltd., Pharmaceuticals &
         Healthcare, Deals By Region, 2007 to YTD 2013                                    Healthcare, Deals By Therapy Area, 2007 to YTD 2013

                         10     8                                                                                         3
          No. of Deals




                         8                                                                                3
                                                                                           No. of Deals




                         6                                                                                                                  2
                         4                                                                                2
                         2                0        0        0        0                                                                                     1
                         0                                                                                1
                              Asia-     Europe   Middle   North    South
                              Pacific             East    Americ    and
                                                  and       a      Central                                0
                                                 Africa            Americ                                             Infectious       Pharmaceut        Central
                                                                     a                                                 Disease           icals and       Nervous
                                                                                                                                        Healthcare       System


         Note: Deals include all announced pharmaceuticals & healthcare deals
         from 2006 onwards, GlobalData                                                    Note: Deals include all announced pharmaceuticals & healthcare deals
                                                                                          from 2006 onwards, GlobalData




Kangmei Pharmaceutical Co., Ltd. - Pharmaceuticals & Healthcare                                                                                   Reference Code: GDPH197245D
- Deals and Alliances Profile
Source : www.globalcompanyintelligence.com                                                                                                                                         Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 3
          List of Figures ................................................................................................................................................................................. 3
       Kangmei Pharmaceutical Co., Ltd., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 ........................................... 4
       Kangmei Pharmaceutical Co., Ltd., Pharmaceuticals & Healthcare Deals By Type, 2007 to YTD 2013 ............................................ 5
       Kangmei Pharmaceutical Co., Ltd., Pharmaceuticals & Healthcare, Deals By Region, 2007 to YTD 2013 ....................................... 6
       Kangmei Pharmaceutical Co., Ltd., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2007 to YTD 2013 ............................. 7
       Kangmei Pharmaceutical Co., Ltd., Pharmaceuticals & Healthcare, Deals Summary, 2007 to YTD 2013......................................... 8
       Kangmei Pharmaceutical Co., Ltd., Pharmaceuticals & Healthcare, Deal Details .............................................................................. 9
          Asset Purchase............................................................................................................................................................................... 9
             Kangmei Pharma To Acquire Pharma Assets From Sichuan Tengwangge And Sichuan Baoning ............................................. 9
          Equity Offering .............................................................................................................................................................................. 10
             Kangmei Pharma Completes Rights Offering Of $510 Million ................................................................................................... 10
             Kangmei Pharma Completes Public Offering Of $212 Million ................................................................................................... 12
          Debt Offering ................................................................................................................................................................................ 13
             Kangmei Pharma Completes Private Placement Of Convertible Bonds For $128.61 Million .................................................... 13
          Acquisition .................................................................................................................................................................................... 14
             Kangmei Pharma To Acquire A Medical Company .
								
To top